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Transcriptional Activation of the e-mye Proto-
Oncogene in Murine Keratinocytes Enhances the 
Response to Epidermal Growth Fac~or 
Michael Reiss, M.D., Christy L. Dibble, B.Sc., and Ramaswamy Narayanan, Ph.D. 
Departments of Medicine (MR, CD) and Pharmacology (RN), Yale Comprehensive Cancer Center, Yale University School of 
Medicine, New Haven, Connecticut, U.S.A. 
To investigate the relationship between activation of the 
c-myc proto-oncogene and the controls of cellular growth and 
differentiation of epidermal cells, a transcriptionally acti-
vated c-myc gene (DM-myc) was introduced into the estab-
lished murine keratinocytes, BALB/MK. Exponential 
growth rates of myc-transfectants were not significantly dif-
ferent from that of parental BALB/MK cells. C-myc RNA 
transcripts were not detectable in confluent, mitogen-de-
prived cultures of parental BALB /MK cells, whereas four out 
of five clones expressed elevated levels of myc mRNA under 
these conditions. All of the cell lines, however, displayed 
density-dependent growth arrest in the GO/I phase of the cell 
cycle. Maximal stimulation of quiescent BALB/MK cells 
with epidermal growth factor (EGF) caused a 70- to 100-fold 
increase of [methyPH]-thymidine incorporation into DNA. 
M ost human malignancies arise in epithelial tissues. In recent years, cellular proto-oncogenes have been identified as targets for carcinogenetic events [1]. Therefore, the identification of the functional significance of proto-oncogenes in the 
regulation of epithel ial cell growth and differentiation could have a 
major impact on the diagnosis and treatment of cancer. Proto-onco-
genes are often homologous to known retroviral transforming 
genes, are present in an activated form in a number of human 
tumors, and appear to encode growth factors, growth factor recep-
tors, or proteins involved in the intracellular transduction of mito-
genic signals [1]. The introduction of oncogenes into un trans-
formed cells represents a powerful technique to identify their 
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In the four subclones that expressed the myc gene, the peak 
thymidine incorporation into DNA was significantly higher 
than in BALB/MK cells, ranging from 340- to 650-fold 
control levels. This increased sensitivity to EGF was not due 
to autocrine mitogenic activity or to a chapge of EGF bind-
ing. Type beta transforming growth factor strongly inhibited 
the EGF-induced DNA synthesis in BALB/MK cultures as 
well as in each of the five transfectants (iCso 4-40 pM). 
Furthermore, both BALB/MK cells and the transfccted sub-
clones could be induced to form cornified cell envelopes by 
increasing the extracellular concentration of calcium. Thus, 
the constitutive expression of c-myc in BALB/MK appears to 
affect predominantly the reinitiation of DNA synthesis by 
EGF.] Invest DermatoI93:136-141, 1989 
biologic effects. For example, by using this approach, two comple-
mentary classes of transforming genes have been found to be re-
quired for the malignant transformation of primary rodent fibro-
blasts [2]. Thus, nuclear oncogenes, such as c-myc, adenovirus EtA 
and p53, facilitate the establishment of primary cells in culture, but 
require the simultaneous activation of a gene of the second class, 
such as one of the ras genes. to induce tumorigenicity [2] . A number 
of studies have shown that activation of oncogenes in mesenchymal 
cells often leads to a loss of their requirements for particular growth 
factors [3,4]. 
The role of oncogenes in the transformation of epidermal cells is 
much less clear than in mesenchymal tissues. One important reason 
for this disparity is the fact that transformed keratinocytes cannot be 
easily detected by morphologic changes in vitro, such as focus for-
mation. Thus far members of the ras family of oncogenes have been 
shown to contribute to the formation of papillomas and carcinomas 
in experimental systems [5,6]. The myc gene has been found to be 
transcriptionally activated in adenocarcinomas of the colon and 
squamous cancer of the cervix, but the functional significance of 
these findings is not clear [7,8]. 
We report here the results of an investigation into the biologic 
effects of activation of the c-myc oncogene in epidermal cells by 
examining the cellular responses to stimulation as well as inhibition 
of cell proliferation. A genetic construct (DM-myc [9]) that com-
prises the second and third coding exon of the human c-myc gene 
under transcriptional control of a retroviral promoter, as well as the 
gene for aminoglycoside phosphotransferase, was introduced into 
the established murine keratinocyte cell line, BALB/MK [10]. Four 
individual subclones, which were obtained by selection for resist-
ance to the antibiotic Geneticin (G418), constitutively expressed 
the transfected gene sequences and displayed an increased respon-
0022-202X/89/S03.50 Copyright © 1989 by The Society for Investigative Dermatology, Inc. 
136 
VOL. 93, NO.1 JULY 1989 
siveness to mitogenic stimulation by epidermal growth factor 
(EGF). This enhanced sensitivity to EGF was not the result of auto-
crine mitogenic stimulation or to changes ofEGF-binding. In these 
cell lines, the constitutively activated mye gene did not affect the rate 
of exponential growth, growth arrest at confluency or in the pres-
ence of type p-transforming growth factor (TGFP), or the expres-
sion of the keratinized phenotype. Thus, an increased responsive-
ness to mitogenic stimulation by EGF was the sole phenotypic 
change that resulted from the constitutive expression of the e-mye 
gene in mouse epidermal cells. 
MATERIALS AND METHODS 
Materials Epidermal growth factor, insulin, transferrin, and so-
dium selenate were obtained from Collaborative Research, Bedford, 
MA. Transforming growth factor beta, isolated from human plate-
lets [11], was a gift from Dr. Richard K. Assoian, NCI. 
Cell Culture The spontaneously immortalized mouse epidermal 
cell line BALB/MK (previously referred to as BALB/MK-2), was 
obtained from Dr. Bernard E. Weissmann, Los Angeles, CA [12]. 
Mycoplasmal contamination of BALB/MK cells was excluded by 
the method described by Chen [13]. Cells were routinely propa-
gated in plastic tissue culture flasks (Costar, Cambridge, MA) in 
standard medium, which consisted of three parts of calcium-free 
Dulbecco's modification of Eagle's medium and one part of Ham's 
F12 medium (Grand Island Biological Company, Grand Island, 
NY), supplemented with 5% (v Iv) fetal bovine serum (FBS, 
GIBCO), insulin (5,ug/ml), transferrin (5,ug/ml), selenium 
(5 ng/ml), EGF (10 ng/ml), and gentamicin (5 Jlg/ml). "Defined 
medium" refers to standard medium from which FBS and EGF 
were omitted. 
DNA-Mediated Gene Transfer The genetic construct, DM-
mye, that comprised the second and third exon of the human e-mye 
gene driven by a murine leukemia virus promoter and was sub-
cloned into pSV2 neo, was obtained from Dr. W. M. F. Lee, Los 
Angeles, CA [9]. PreconiJ.uent BALB/MK cells were collected by 
centrifugation after trypsinization and resuspended in 0.5 ml of 
ice-cold calcium- and magnesium-free phosphate-buffered saline 
(PBS), at 4 X 107 cells/ml. Transfection with 50,ug DNA by elec-
troporation was carried out as described previously [10] . Selection of 
individual drug-resistant clones was performed in medium contain-
ing 150,ug/ml Geneticin (G-418, GIBCO). Individual colonies 
were picked using cloning cylinders, and expanded for further ge-
netic and phenotypic analysis. 
Detection of Integrated Gene Sequences and DNA Tran-
scription Genomic DNA from BALB/MK cells and transfected 
clones was isolated as described by Blin and Stafford [14]. Equal 
amounts of DNA from each cell line were subjected to electropho-
resis on 1 % (w Iv) agarose gels, and then transferred onto nitrocellu-
lose paper as described by Southern [15]. Dried and baked filters 
were then hybridized with a [32P]-labeled second exon-specific 
e-mye fragment as probe (specific activity: > 108 cpm/,ug DNA), and 
hybridizing sequences visualized by autoradiography. Conditions 
of high stringency were used for both the hybridization and the 
washing procedure. Total cellular RNA was extracted from cells 
grown to confluency using guanidinium isothiocyanate, and cen-
trifugation over a cesium chloride gradient, as described by Ullrich 
et al [16]. After electrophoresis on a formaldehyde-containing agar-
ose gel [17], the RNA was transferred to nitrocellulose paper and 
hybridized under conditions of high stringency with a [32P]-labeled 
second exon-specific e-mye DNA fragment, and visualized by auto-
radiography. 
Characterization of Cell Growth Cells were plated at 2.5 X 
104 cells per cm2 in 35-mm wells, and cell numbers determined at 
24-h intervals in duplicate wells after detaching the cells with 
0.05% (w/v) trypsin-0.02 mM EDTA (GIBCO). Doubling times 
were derived from the logarithmic portion of the growth curves 
obtained. 
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Cell Cycle Analysis Cells were detached from the tissue culture 
plates, collected by low-speed centrifugation, and the cell pellets 
resuspended in 1 ml PBS while titurating vigorously. Cells were 
fixed by the drop-wise addition of 3 ml of 100% (v Iv) ethanol 
while vortexing, stained with 10 mg/ml propidium iodide (Sigma, 
St. Louis, MO), and subjected to flow cytophotometry using a Bec-
ton-Dickinson FACS IV cell-sorter. Relative proportions of cells in 
the Go/!, S, and G2/M phases of the cell-cycle were derived by 
calculation from computer printouts. 
Measurement of DNA Synthesis The standard medium in con-
fluent cultures was replaced with fresh defined medium. After 24 h, 
growth factors were added, and, 20 h later, the cultures were labeled 
with 1.5 ,uCi/ ml [methyPH]-thymidine (60- 70 Ci/mmol, ICN 
Biochemicals, Irvine, CA) at a final specific activity of 150 Ci/ 
mole, for 2 h at 37 ° C. In control experiments, we have found that at 
a concentration of total thymidine in the medium of 10 ,uM, the 
contribution of endogenously synthesized thymidine to DNA syn-
thesis is minimized, without a significant inhibition of the endoge-
nous synthesis of nucleotides . Cold trichloroacetic acid-precipita-
ble, hot perchloric acid-soluble radioactivity was determined in a 
Beckman LS 7500 scintillation spectrometer after addition of Opti-
fluor (Packard Instr. Co., Inc., Downers Grove, IL). Where indi-
cated, DNA synthesis of BALB/MK cells was determined at 20 h 
after replacing the medium in the test wells by conditioned medium 
from the various transfectants, in the absence or presence of EGF. 
Conditioned medium was collected as follows: Cells were grown to 
confluency and the medium entirely replaced by defined medium. 
After 24 h, this medium was discarded and replaced by fresh defined 
medium. This was collected 3 times at 48-h intervals, pooled, and 
stored frozen until analysis. 
Binding of (125-I]-Labeled Epidermal Growth Factor Cells 
were plated in 24-well cluster dishes (105 cells/well) in complete 
medium. When the cultures reached confluency 48 to 72 h later, 
the medium was entirely replaced with defined medium that did not 
contain EGF. Twenty-four hours later, the monolayers were 
washed twice with ice-cold binding buffer (calcium-free Dul-
becco's modification of Eagle's medium, 0.5% (w I v) bovine serum 
albumen, 50 mM HEPES, pH 7.5) and duplicate wells incubated 
with 50,u1 of binding buffer containing 15 nM (12s-I]-EGF (150 -
200 ILCi/ml, New England Nuclear, Boston, MA) for 4 h at 4°C. 
The wells were then washed rapidly 6 times with 0.5 ml of ice-cold 
binding buffer and the cells solubilized in 0.5 ml/well of 1 N 
NaOH, 0.1 % (w Iv) sodium dodecyl sulfate for 30 min at room 
tem.perature. Radioactivity in the solution was determined in a LKB 
rack gamma counter. Nonspecific binding was determined in the 
presence of a 100-fold molar excess of unlabeled EGF (CR-EGF, 
receptor grade, Collaborative Research, Bedford, MA). In experi-
ments in which cells were treated with EGF before the binding 
assay, unlabeled EGF was removed from the cells by washing the 
monolayers with 50 mM glycine, 100 mM NaCI (pH 4.0) before 
incubation with [!2S_I]_EGF. 
Cornified Cell Envelope Formation Cells insoluble in 1 % 
(w I v) sodium dodecyl sulfate-l0 mM dithiotreitol were deter-
mined by counting using a hemocytometer under phase optics, and 
expressed as a fraction of total cells, as described previously [18] . 
RESULTS 
Transfection of BALB/MK cells with DM-mye plasmid DNA by 
electroporation yielded approximately 40 G418-resistant clones 
(i.e., 7 clones per 105 cells plated). As the morphology of the pri-
mary colonies was indistinguishable from the parental BALB/MK 
cells, individual clones were expanded in culture under continuous 
selection pressure with G418 for further studies. This report de-
scribes the phenotypic analysis of five randomly selected BALB/ 
MK clones transfected with DM-myc. Figure 1 shows that DM-
mye-specific sequences could be detected in each of these five clones 
by Southern blot analysis. The DM-mye construct contains two Sac I 
restriction sites that flank a DNA fragment of 2.8 kb, one in the 
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Figure 1. DetectiOl~ of myc sequences in BALB/MK cells, and DM-myc-
transfected clones. DNA was isolated from BALB/MK cells and from five 
DM-myc-transfected clones, and digested to. completion with ~ac 1. The 
DM-rnyc construct contains two Sac I restnctIon sites encompassmg a fra~­
ment of 2.8 kb, one of which is localized m the MLV L TR and the other m 
the second coding exon of the myc gene. The DNA digests were resolved on 
a 1 % (w Iv) agarose gel (10 f.lg DNA per lane), and transferred .to nitr3~cellu­
lose paper. After hybridization under stringent conditIOns with a [ P)-Ia-
beled human c-myc exon 2 probe, myc specific sequences were detected by 
autoradiography. Numbers over each lane correspond to DM-myc transfec-
tants. A mixture of Hind III restriction fragments of A. phage DNA and 
H aeIll restriction fragments of ¢X 174 phage DNA was used as molecular 
size markers (in kilobasepairs). 
murine leukemia virus promoter region and another within the 
second coding exon of c-myc. Thus, hybridization of Sac I digests of 
genomic DNA of each of the five transfectants (#1A, 5, 6, 8, and 10) 
with a second-exon specific c-myc fragment as probe, revealed the 
presence of a single band of 2.8 kb as predicted for the DM-myc 
plasmid [9] (Fig 1). In addition, clone #6 contained a second, 
strongly hybridizing, myc-specific band of 3.5 kb. This observation 
(in two different DNA preparations of clone #6) suggests that the 
DM-myc DNA had undergone rearrangement during integration in 
this particular clone (Fig 1). The variation in intensity of the extra-
neous band was due to small differences in the amounts of DNA 
loaded onto the gel. We estimate that the transfectants had taken up 
1 to 2 copies of DM-myc per haploid genome. 
Expression of the myc gene was evaluated in density-arrested cul-
tures: Cells were grown to confluence in standard medium, which 
was then replaced with the defined medium that did not contain 
serum or EGF. Under these conditions, cell proliferation ceases and 
DNA synthesis remains at very low levels [19]. As shown in Figure 
2, no endogenous c-myc mRNA transcripts were detected in quies-
cent parental cells or in clone #6, in which the transfected sequences 
had been rearranged. However, a DM-myc-specific RNA transcript 
of approximately 2.6 kb was clearly detectable in four out of five 
subclones, even though the cells were proliferatively quiescent 
(Fig 2). 
The biologic effects of the constitutive expression of the exoge-
nous c-myc sequences on the regulation of cell growth and differen-
tiation of MK cells was investigated by using a number of different 
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Figure 2. Transcription of myc-related sequences in BALB/MK cells, and 
DM-myc-transfected clones. BALB/MK cells and DM-myc-transfected 
clones were grown to confluency, and total cellular RNA isolated as de-
scribed in Materials and Methods. Ten f.lg of RNA from each cell line was 
resolved in a formaldehyde-agarose gel, and transferred to a nitrocellulose 
filter. After hybridization under stringent conditions with a [32P)-labeled 
human c-myc exon 2 probe, myc-specific RNA sequences were detected by 
autoradiography. A 2.6-kb RNA transcript, derived from the DM-myc con-
struct, was present in clones #lA, 5, 8, and 10 but not in clone #6, or in the 
parent cell line (BALB/MK) . Hind III restriction fragments of A. phage 
DNA were used as molecular weight markers (in kilobase pairs). 
in vitro assays. As shown in Table I, the exponential growth rate of 
three of the four myc-expressing clones was higher than that of 
parental BALB /MK cells. However, we found no differences in cell 
density at confluence among the six cell lines (data not shown). We 
have reported previously that when mitogens such as EGF and FBS 
were removed from the medium in confluent BALB/MK cultures, 
cells displayed density-dependent growth arrest [19]. Flow cytome-
try showed that under these conditions, greater than 90% of the cell 
population was found in the Gq;1 phases of the cell cycle (Table II) . 
Each of the five DM-myc-transtected cell clones also displayed cell-
cycle arrest under these conditions (Table II). As predicted by the 
cell-cycle analysis, the incorporation of tritiated thymidine into 
DNA was extremely low when confluent DM-myc-transfected MK 
cells were maintained in defined medium for 24 h, and did not 
differ significantly from that of parental BALB/MK cells (BALB/ 
MK: 11.3 ± 3 X 1000 dpm/well; DM-myc clones: 8.4 ± 4 X 
1000 dpm/well). Therefore, these cell lines remained responsive to 
density-dependent growth arrest in spite of the constitutive expres-
sion of c-myc. 
Table I. Doubling Times of DM-myc-Transfected 
BALB/MK Clones 
Clone 
BALB/MK 
#lA 
#5 
#6 
#8 
#10 
Doubling Times (h) 
20.4 
20.3 
13.0 
21.1 
13.4 
17.5 
Cells were plated in standard medium at 2.5 X 10' cells/em2• At intervals of24 h, 
cells were detached from the dishes using trypsin-EDTA, the number of cells deter-
mined by using a Coulter particle counter, and growth curves constructed. The dou-
bling times were derived from the log-linear portions of these curves. Each data point 
represents the mean of two experiments (triplicate dishes in each). 
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Table II. Cell-Cycle Distribution of Confluent DM-mye-
Transfected BALB/MK Clones 
C lones 
Cell -Cycle 
Phase BALB/MK # IA #5 #6 #8 #10 
GO/I 94 97 97 96 96 98 
S 2 1 1 1 3 1 
Gz 4 2 2 3 1 1 
Cells were grown to connuency in serum-supplemented medium. The standard 
medium was then entirely rep laced with defined med ium without added EGF as de-
scribed in Materi"ls alld Methods, and incubated for an additional 24 h. Cells were 
collected by trypsinization, fixed as a single-cell suspension, stained with propidium 
iod ide, and th e DNA contents determined usi ng a fluorescence-actlva.ted cel l sorter. 
The data represent the relative proportions of the cel l populations in the Go/ l , S, and 
Gz/M phases of the cel l cycle as ca lculated from computer printouts of cell numbers per 
channel (numbers indicate percentages of total cel ls, at least 30,000 cells/sample 
counted). 
Activation of the l1lye gene in fibroblasts apparently results .in a 
loss of the requirements for mitogens, such as platelet-derIved 
growth factor (PDGF) and EGF [3,4). Therefore, we investigated 
the response of DM-l1lye transfectants to mitogenic stimulation. 
The response to EGF of the four cell lines that constitutively ex-
pressed exogenous e-mye at high levels (i .e:, #1~, 5, 8, and 10) 
differed significantly from the pareI~t cell hne (Fig 3). ~ e l~ave 
shown previously that the incorporation of ~ntlated thymldl11e .lI1to 
DNA of quiescent BALB/MK cells was stmmlated exponentially 
by EGF in the range of 1 to 10 ng/ml, and reached a platea~ at 
100 ng/ml EGF [19). As shown in Figure 3, treatment of denslty-
arrested BALB/MK cells with 100 ng/ml EGF resulted 111 a 70- to 
110-fold stimulation of DNA synthesis. Quiescent DM-l1lye-trans-
fected cell clones #lA, 5, 8, and 10 were also stimulated by EGF to 
undergo DNA synthesis in a dose-dependent manner. In each case, 
stimulation increased exponentially over the range ofl to 10 ng/ml 
EGF, and the position of the dose-response curve was not shifted 
compared with that of the parental cells. The maximal stimulation 
of DNA synthesis by EGF in the DM-l1lye-transfected cell clones 
#1A, 5, 8, and 10, however, ranged from 340- to 650-fold (Fig 3). 
In contrast, clone #6, which did not express e-mye in the quiescent 
state, responded to EGF with the same sensitivity as th.e par~nt cell 
line (Fig 3). Thus, the maximum level of DNA syntheSIS achievable 
with EGF was significantly higher in the clones that expressed e-mye 
constitutively than in BALB/MK cells or clone #6, although the 
dose-range in which EGF was active was not altered by l1lye expres-
sion. 
To determine whether changes in the expression of cell surface 
receptors for EGF might account for the enhanced response ofDM-
1I1yc transfectants to EGF, we examined the kinetics ofEGF bindl11g. 
As shown in Table III, quiescent BALB/MK cells e:cpre~sed.ap'prox­
imately 23 000 EGF receptors per cell, a value that IS qUite sunllar to 
that recent'ly reported by Zendegui et al [20] for the same cell line. 
Furthermore, the numbers of EGF receptors on the DM-I1l)'e trans-
fectants (ranging from 19.500 - 24.400 per cell) were not signifi-
cantly different from those on the parental cell line (Table III). 
Zendegu i et al [20) also showed that exposure ofBALB/MK cells to 
EGF resulted in a down-regulation of the number ofEGF receptors. 
Because of the possibility that the enhanced response of the DM-
myc transfectants to EGF might be due to a failure of EGF receptors 
to be down-regulated, we measured EGF binding after exposure of 
cells to EGF for 24 h. As shown in Table III, treatment with EGF 
resu lted in a 30 - 55% reduction ofEGF-binding sites in BALB/MK 
cells as well as in clones #lA, 6, 8, and 10. Although EGF-receptors 
were not down-regulated in clone #5, this is unlikely to be the sole 
explanation of this cell line's enhanced response to EGF, as ~he same 
phenomenon was not seen in the other three myc-expresslllg sub-
lines. 
W e investigated the possibility that the amplified response to 
EGF exhibited by the four DM-lIlyc transfectants was the result of 
the autocrine production of a mitogen. Conditioned medium was 
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Figure 3_ Effect ofEGF on DNA synthesis ofDM-myc-transfected BALB/ 
MK clones. Cells were grown to confluency in 6-well plates, and the stan-
dard medium entirely replaced with fresh defined medlllm wIthout added 
EGF. After 24 h, EGF (10 ng/ml) was added. At 22 h, cells were incubated 
for 2 h at 37"C in the presence of [methyPHJ-thymidine (1 .5 ttei/well). 
The amount of cold TCA-precipitable, hot perchloric acid-soluble radiola-
beled material in each well was determined. In the absence ofEGF, BALB/ 
MK cel ls incorporated 8.44 ± 0.7 X 1000 dpm/well, and, when treated 
with EGF (10 ng/ ml), 705.86 ± 72.2 X 1000 dpm/ well. The difference in 
numbers of cells per well between the different cell lines was less than 10%. 
In the figure, data a.re expressed as multiples of control levels of incorpora-
tion. Mean and SEM from five separate experiments. 
collected from each of the transfectants, and tested for the presence 
of mitogenic activity on quiescent cultures of parental BALB/MK 
cells. Table IV shows that Ilone of these clones appeared to secrete a 
mitogenic product. In the presence of EGF, however, the l .e~e1 of 
stimulation of DNA synthesis of BALB/MK cells by condltJoned 
medium derived from clones #lA and 5 was lower than the activity 
of conditioned medium derived from parental cells or any of the 
other clones (Table IV). This result suggests that clones #lA and 5 
secreted an inhibitor of EGF. Experiments are ongoing to identify 
this inhibitor. In any event, these findings do not favor the autocrine 
stimulation of mitosis as explanation for the enhanced response to 
EGF seen in the DM-m)'c transfectants. 
We had shown previously that the DNA synthesis induced by 
EGF in BALB/MK cells was strongly inhibited by TGF{l and that 
resistance to TGF{l can occur in human squamous carclllomas 
[1 9,21). Thus, an enhanced response to EGF might be due to rela-
tive insensitivity to TGF{l. However, we found that the ICso of 
TGF/l was between 4 and 40 pM in each of the six cell lines exam-
ined (Fig 4). Thus, the EGF-induced DNA synthesis was inhibited 
by TGF{l as effectively in the transfectants as in parental BALB/MK 
cells. 
Table III. [125-I]-EGF Binding to DM-m)'c-Transfected 
BALB/MK Clones 
C lone 
BALB/ MK 
#1A 
#5 
#6 
#8 
# 10 
Molecules of [125_1]_EGF 
Bound per Cell 
NoEGP WithEGF' 
23.400 13.500 
24.400 15.100 
19.500 18.000 
25.000 16.900 
24.400 13.400 
20.900 9.700 
Cells were grown to conAuency and the medium replaced entirely with defined 
medium that contained either no EGf' or 10 ng/ ml EGF.' After 24 h culrures were 
incubated with 15 nM [12S-IJ-EGF for 4 h ar 4 0c. Nonspecific binding was determined 
in the presellCe of 1.5 11M unlabeled EGF. Values represent the number of speCific 
EGF-bindi ng sites per cell. 
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Table IV. Effects of Conditioned Media of DM-myc-
Transfected Cell Clones on Thymidine Incorporation of 
Quiescent BALB/MK Cells 
Source of 
Conditioned Medium 
BALB/MK 
#lA 
#5 
#8 
#10 
Radioactivity 
(dpm/well X 1000 ± s.e.m.) 
Without 
EGF 
3.60 ± 0.1 
0.75 ± 0.1 
0.80 ± 0.1 
1.30 ± 0.1 
1.20 ± 0.2 
With 
EGF 
397.4 ± 69 
134.7 ± 19 
135.0 ± 2 
430.8 ± 54 
309.5 ± 11 
Conditioned media from parental BALB/MKcells and OM· my' transfected clones 
were coll ected as described in Materials alld Methods. Quiescent cu ltures of parental 
BALB/ MK we re exposed to conditioned medium with or without added EGF (10 
ng/ml) for 22 h , and the incorporation of [3H-methyl]-thymidine determined as de-
scribed in Materials alld Methods. Mea n and SEM of two separate experiments, triplicate 
dishes for each condition. 
Finally, we determined whether constitutive activation of the 
c-myc gene in BALB/MK cells would deregulate the process of 
terminal differentiation. Parental BALB/MK cells undergo termi-
nal differentiation when the extracellular concentration of calcium 
is increased from less than 0.1 mM to more than 1 mM [12]. Con-
flu ent cultures were maintained in defined medium with a calcium 
concentration mor~ than 1 mM for 5 d, and the fraction of cornified 
envelopes ascertained . As shown in Table V, BALB/MK cells, as 
well as each of the transfected clones, could be induced to form 
cornified envelopes in culture to the same degree. Thus, by this 
criterion at least, the process of differentiation was not altered by the 
introduction of an activated myc gene into these epidermal cells. 
DISCUSSION 
The purpose of this investigation was to determine how the activa-
tion of the c-myc oncogene would affect the control of growth and 
differentiation in murine epidermal cells. A genetic construct that 
comprised the coding sequences of the human cellular myc gene 
under transcriptional control of a retroviral promoter appeared to be 
particularly well suited for these studies because it had been shown 
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Figure 4. Effects of TGF/l on the EGF-induced DNA synthesis of OM-
myc-transfected BALB/MK clones. Cells were grown to confluency in 6-
well plates, and the standard medium entirely replaced with fresh defined 
medium without added EGF. After 24 h, EGF (10 ng/ml) was added in 
combination with TGF/lat the concentrations indicated. At 22 h, cells were 
incubated for 2 h at 37"C in the presence of (methyPH]-thymidine (1.5 
,uCi/wcl l) . The amount of cold TCA-precipitable, hot perchloric acid-solu-
ble radiolabeled material in each well was determined, and expressed as a 
fraction of levels of incorporation in the presence of EGF only. 0 BALB/ 
MK; 0 #lA; 0 #5; 0 #6; a #8;. #10. 
Table v. 
THE JOURNAL OF INVESTIGATIVE DERMATOLOGY 
Formation of Cornified Cell Envelopes By DM-myc-
Transfected BALB/MK Clones 
Clone 
BALB/MK 
#lA 
#5 
#6 
#8 
#10 
CCE (%) 
3 -6.5 
4.2-8 
2-18 
2.2 - 5.5 
2- 18 
2.5-9 
Cell s were grown to confluency in6-well plates, and the medium entirely replaced 
with fresh defined medium without added EGF, in which the concentration o f [Ca++] 
was raised to 1.87 mM by the addition of CaCI2 . After 5 d. cells were detached by 
trypsinization, and divided into two aliquots . One was used to determine the total 
number of cells. The other half of the cell s were collected by centrifu gation, and the cell 
pell ets resuspended in 1% (w/v) sodium dodecyl sulfate- IO mM dithiotreitol. The 
number of cornified ce ll envelopes (CCE) were determined by counting using a hemo-
cytometer under phase optics, and expressed as a fraction of total cell numbers. Range of 
three separate experiments. 
previously to possess co-transforming activity in primary rodent 
fibroblasts [9]. 
Two observations in this paper are of significant interest. First, 
the major phenotypic change we observed in DM-myc-transfected 
BALB/MK cells was an enhanced response to the mitogenic activity 
ofEGF. This finding is in agreement with previous studies in which 
myc-transfected heart mesenchymal cells as well as fibroblasts 
showed a similarly amplified proliferative response [3,4,22]. In the 
case of fibroblasts, the hypersensitivity to EGF appeared to be due to 
a loss of the requirement for competence factors such as PDGF [3]. 
In fact, micro injection of myc protein into the nuclei of3T3 cells has 
the same biologic effect as PDGF [23] . As epithelial cells do not 
require or respond to PDGF, other explanations must be sought for 
the hypersensitivity to EGF that we observed in BALB/MK cells. In 
principle, the increased mitogenic response observed in DM-l1Iyc 
transfectants could be due to a greater proportion of cells entering 
the cell cycle or to an increased rate of DNA synthesis in individual 
cells. Cell-cycle analysis of cultures exposed to EGF for 22 h 
showed no significant difference in the proportion of cells in S-
phase in BALB/MK or DM-myc transfected cells (data not shown). 
Thus, l1Iyc expression does not appear to increase the proportion of 
cells that are able to respond to mitogenic stimulation. Although 
not evident from the cell-cycle analysis or from the time course of 
EGF-induced DNA synthesis in the myc-transfectants, we cannot 
exclude the possibility that small changes in the kinetics of entry of 
quiescent cells into S-phase contributed to the increased levels of 
thymidine incorporation that we observed, if, for example, the 
transfectants were arres ted at a slightly later point of the Go/ ! phase. 
On the other hand, one might propose one of a number of different 
mechanisms to account for an increased rate of DNA synthesis in 
individual cells: 1) increased autocrine secretion of mitogens; 2) 
alteration of the EGF receptors; and 3) alteration of the transduction 
of the EGF-induced signal within the cell. Pragnell et al [24] have 
reported recently that myc-transfected fibroblasts produced small 
amounts of type alpha transforming growth factor, but this was not 
confirmed in another study by Stern et al [4]. Similarly, we did not 
detect any autocrine mitogenic activity in conditioned medium de-
rived from the transfected clones, although it is possible that small 
amounts of mitogen would not have been detected because the 
sensitivity of our bioassay is 1 ng EGF /m!' Second, when we deter-
mined the characteristics of EGF binding, we found that the num-
ber of EGF receptors on BALB/MK cells and the DM-myc-trans-
fected cells were not significantly different (Table III). Similarly, 
Stern et al [4] have shown that the number of EGF receptors was 
only marginally decreased in l1Iyc-transfected Fischer rat 3T3 cells. 
Furthermore, as described previously by Zendegui et al [20], EGF 
receptors on BALB/MK cells were down-regulated by treatment 
withEGF (Table III). Although no down-regulation ofEGF recep-
tors occurred in clone #5, this is not a satisfactory explanation for 
this cell line's enhanced response to EGF, as EGF receptors were 
appropriately down-regulated in the other l1Iyc-expressing clones, 
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#lA, 8, and 10. In view of the nuclear localization and the DNA-
binding characteristics of the mye protein [25] perhaps the most 
likely explanation for the amplified response to EGF lies in a distur-
bance of the transduction of its signal within the cell. The question 
whether expllession of mye protein is necessary for, or simply ampli-
fies the mitogenic stimulus, might be resolved by selectively inhib-
iting the function of the protein with specific antibodies, or pre-
venting transcription of the gene with, for example, antisense 
mye-specific mRNA in normal cells. 
On the other hand, the apparent enhanced sensitivity to EGF 
could also be a manifestation of a decreased response to growth-in-
hibitory factors . In this regard, the second important observation in 
this report is the fact that the introduction of a constitutively active 
mye gene into epidermal cells did not result in the disruption of any 
of three types of growth inhibition: 1) density-dependent growth 
arrest; 2) exposure to TGFfJ; and 3) calcium-induced terminal cell-
differentiation. Thus, although DM-mye transfectants were more 
responsive to EGF, they still required an exogenous mitogenic sig-
nal to continue to proliferate after reaching confluency. The obser-
vation that DM-mye transfection did not alter the response of 
BALB/MK cells to TGFfJ is of special interest in view of a recent 
report by Leof et al [26] . These investigators found that TGFfJ could 
induce anchorage-independent growth in mye-transfected 
C3H/10T1/ 2 cells, but not in untransfected cells. On the other 
hand, Stern et al [4] did not observe an altered response of mye-trans-
fected Fischer rat 3T3 cells to TGFfJ. The differences between these 
findings might be due to variations in experimental conditions or to 
tissue-type-specific effects of e-mye gene activation. Our observation 
that conditioned medium derived from clones #lA and 5 apparently 
contained a growth inhibitor suggests one possible mechanism 
whereby these cells might compensate for the increased sensitivity 
to a mitogen. As Coffey et al [27] have shown recently, BALB/MK 
cells themselves produce TGFfJ, the secretion of which might be 
increased in clones #lA and 5. This question is currently under 
investigation. 
The process of calcium-induced differentiation was not disturbed 
in the DM-mye transfected BALB/MK cells. In contrast, previous 
studies have shown that transfection of activated ras, abl, or sre 
oncogenes into BALB/MK cells resulted in a resistance to the in-
duction of terminal differentiation, in addition to a decreased re-
quirement for EGF [12,28]. Thus, the role of the mye gene in epi-
dermal cells appears to be distinct from that of the other cellular 
proto-oncogenes mentioned above. Complementation experiments 
are in progress to determine the relative contribution of an activated 
mye gene and other oncogenes to the full-fledged transformation of 
BALB/MK cells. 
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